1. Introduction
As our body’s biggest surface, skin is involuntarily exposed to both abiotic [1,2] and biotic elements [3,4] because it engages with extraneous environments, whereas voluntary exposure is attributed to the use of cosmetics and personal products. Because the majority of these products are applied and used in a myriad of ways every day, it is assumed that the products boost our appearance and personal hygiene because they are purported to be safe for use/consumption. Considering the frequency of skin contact as well as the mucosa, it is paramount to ensure that the products do not comprise hazardous substances. In fact, each ingredient utilized in cosmetics products should comply with regulatory norms [5]. In addition, it is important to consider these products’ long-term side effects [6,7]. At the same time, other substances could cause many side effects like allergies and dermatitis [8].
Considering the United Arab Emirates’ (UAE’s), regulations, cosmetics products must not cause any harm to consumers’ health and safety under foreseeable or normal scenarios. To that end, the role of manufacturers in ensuring the safety of these products becomes paramount, as they are the ones responsible for a product’s launch. However, in this context, safety is not confined to preventing the use of banned chemical substances; it also entails appropriate stability and purity on microbiological levels. Because it is imperative to guarantee this, producers tend to depend on preservatives, typically synthetic compounds such as Alkyl (C12-22) trimethyl ammonium bromide and chloride, for example, Behentrimonium chloride and Cetrimonium chloride. Due to the extensive use of Cetrimonium chloride, people are expected to gain exposure to such compounds for a prolonged period.
Cetrimonium chloride has anti-frizz, detangling, and anti-static attributes. In cosmetics products, the ingredient’s chemical structure enables its use in formulating hair care products like colors and hair dyes. Cetrimonium chloride also helps clean the skin by curtailing microorganisms’ growth as well as by mixing water with dirt and oil to allow for rinsing. It bears a strong resemblance to Behentrimonium chloride, a conditioning ingredient. The difference lies only in carbon atoms, as, due to its intrinsic lightness, it makes slight alterations in how the conditioner feels after application to the hair.
State regulations strongly control Cetrimonium chloride’s concentration in cosmetics personal care and cosmetics products. The Cosmetics Regulation (EC) No 1223/2009 suggests that the concentration of substances identified by the denominations of alkyl (C12-22) trimethyl ammonium bromide and chloride as preservatives is 0.1%. The recommended Cetrimonium chloride level in rinse-off hair products is 2.5%, while the recommended levels are 1% in leave-on hair products and 0.5% in leave-on face products. Moreover, the recommended Behentrimonium chloride level in rinse-off hair products is 5%, while the recommended levels are 3% in rinse-off hair products and 3% in leave-on face products [9]. Similarly, the UAE cosmetics technical regulations are adopted from EU regulations and apply the same concentrations limit in cosmetics and personal care products [10].
However, despite the regulations, many instances of tainted cosmetics products have been found in the UAE. As a case in point, a study on the UAE’s personal care/cosmetics products revealed that 13% of the products tested contained higher than recommended levels of formaldehyde, and not even a single product was labeled formaldehyde or formaldehyde-free [11].
Research shows that 5% of the 100 products (personal care and cosmetics) tested in the UAE were infested by aerobic mesophilic bacteria, while 13% of products contained mold or yeast [12]. Another study assessing the safety of cosmetics products in Dubai revealed that six of the 102 hand sanitizers (alcohol-based) contained unlisted/undeclared methanol, with other samples comprising below 60% alcohol, although their labels suggested that they contained 70% alcohol content [13,14,15].
This study quantifies and investigates Cetrimonium chloride and Behentrimonium chloride in the cosmetics and personal care products in the UAE market to gauge whether or not they adhere to requirements for safety and health. Its findings will help ensure compliance with existing regulations and enhance the inspection and regulation of cosmetics containing Behentrimonium chloride/Cetrimonium chloride preservatives.
2. Methods and Materials
2.1. Sample Collection
This study searched local business directors to identify the outlets that sell personal care/cosmetics products and contain information about each healthcare and pharmacy/para-pharma retailer in the UAE. After 2183 such retailers were identified, a sample framework was created using an Excel spreadsheet. It contained all of the pertinent information, such as business names, emails, phone numbers, and addresses. Then, a study sample was created by adopting basic selection (random-sample) based on business ID numbers, and stratification was implemented based on location/type. The criterion for selecting products was that their label must consist of Behentrimonium chloride or Cetrimonium chloride. Across all locations, a package of all personal care/cosmetics products was randomly selected regardless of their place of manufacturing. Then, a reference number (code) was assigned to each item to facilitate tracking and prevent duplication. For each sample, the details were noted in the following manner: brand name, product name, category of item, manufacturer’s country, dosage form, subcategory, size/volume, bar code, batch number, recommended dosage, and shop location. If identical products were seen for more than one outlet (that is, manufacturer/name/barcode/volume/size/formulation), the first product to be selected underwent testing and the rest were returned. If different firms shared a common product name or were found in several formats, they were deemed separate. In addition, in that case, both products underwent testing. All the chosen products were dispatched to a laboratory where they were assessed on the day of collection.
2.2. Measurement of Cetrimonium Chloride and Behentrimonium Chloride Content (Procedure Summary)
A gas chromatography–mass spectrometry (GC–MS) method is developed and validated for the determination of Cetrimonium chloride and Behentrimonium chloride surfactants in hair products. Sodium Dibutylnaphthalenesulfonate is used as an internal standard. The limit of quantitation (LOQ) is 0.5 ng/mL with a signal-to-noise ratio greater than 5. The calibration curve is linear from 0.5 to 250 ng/mL with an R2 greater than 0.99. The coefficients of variation for within-and between-assay imprecision, including LOQ, are ≤ 15% and ≤ 8%, respectively. The percentage of inaccuracy for within- and between-assay, including LOQ, are ≤ 9% and ≤ 5%, respectively. The percentage determinations of Cetrimonium chloride and Behentrimonium chloride are greater than 84% and 82%, respectively.
2.3. Apparatus
Solvent delivery was achieved using a Shimadzu GCMS-QP2010 SE set at 1 mL/min. Sample injection was carried out using a Shimadzu AOC 30 series autoinjector. A Shimadzu column oven containing 5%-phenyl-95%-dimethylpolysiloxane was used. Detection was by MS-QP2010 SE. All PE SCIEX software was supplied by Shimadzu. The NM20ZA high-purity nitrogen and air generators were supplied by Shimadzu.
2.4. Chromatographic System
A Shimadzu column oven containing 5%-phenyl-95%-dimethylpolysiloxane was used. The mobile phase 99.99% used which was generated by a nitrogen generator. The flow rate was fixed at 1 mL/min. The GCMS-QP2010 SE is a single quadrupole gas chromatograph–mass spectrometer. The sample injection volume was 10 µL for MS. Nitrogen was used as the collision gas. Lab solution software was used to control the GC–MS, record the output from the detector, perform integration of peak areas, and calculate the concentrations of Cetrimonium chloride and Behentrimonium chloride. Dibutylnaphthalenesulfonate was used as an IS. All calculations were based on peak-area ratios of Cetrimonium chloride, Behentrimonium chloride, and IS. The precursor ions for Cetrimonium chloride, Behentrimonium chloride, and Dibutylnaphthalenesulfonate were m/z 348.96, 334.98, and 385.98, respectively, while after collisional dissociation, the product ions were 92.77, 95.66, and 152.86, respectively. The retention times for Cetrimonium chloride, Behentrimonium chloride, and Dibutylnaphthalenesulfonate during the assay were 6.2, 5.7, and 4.5 min.
2.5. Assay Procedure
Stock solution A of Cetrimonium chloride and Behentrimonium chloride was prepared in methanol. All the sub stock solutions were stored frozen at approximately −20 °C. All the calibrators and quality control (QC) sample concentrations were prepared by appropriate dilution of the sub stock dilution. The contents were mixed for a minimum of 5 min by the shaker and then centrifuged at 3000–3500 rpm for 5 min. The top layer was then transferred into an autosampler vial. A 10-µL volume was injected into GCMS.
2.6. Selection of Operating Protonated Ions
The chemical structure and protonated ions of Cetrimonium chloride, Behentrimonium chloride, and Dibutylnaphthalenesulfonate used in this study related to their mass. The fragment ions at m/z 92.77 for Cetrimonium chloride, m/z 95.66 for Behentrimonium chloride, and 152.86 Dibutylnaphthalenesulfonate were selected for the assay.
2.7. Specificity
No significant interfering peaks were found in the retention times of Cetrimonium chloride and Behentrimonium chloride. The signal-to-noise ratios for both drugs were greater than 5 shows the chromatogram obtained from blank methanol.
2.8. Calibration Curve
The calibration curve covered the range from 0.5 to 250 ng/mL of Cetrimonium chloride and Behentrimonium chloride with seven calibrators. All of the results were calculated using a 1/×2 weighted quadratic regression. The peak-area ratio, regression coefficient, and parameters of the calibration line were calculated from the peak area data by the analyst program. The regression coefficient for all the calibration curves was greater than 0.99. Mean results obtained from five curves are summarized.
2.9. Ethical Consideration
The Institutional Review Board of An-Najah National University approved this study. Reference number: lnt.R. March.2021/10.
2.10. Statistical Analysis
SPSS version 24 obtained from Chicago, IL (USA) was used to carry out data analysis. In this analysis, a summary of qualitative variables was provided using percentages and frequencies. With each product, Cetrimonium chloride and Behentrimonium chloride (%) were calculated. To test cross-group differences in Cetrimonium chloride and Behentrimonium chloride (%), Kruskal–Wallis test was applied. p-values < 0.05 were chosen as the statistically significant boundary.
3. Results
3.1. Sample Characteristics
Table 1 displays the sample baseline characteristics of the cosmetics and personal care products. A total of 164 cosmetics products were collected and analyzed in this study. Of this total, 97% (n = 159) were hair and scalp products while 3% (n = 5) were face and neck preparations. Among the analyzed samples, 125 (76.2%) were rinse-off cosmetics and 39 (23.8%) were leave-on cosmetics. The product countries of origin were as follows: 16 (9.8%) United States, 10 (6.1%) United Arab Emirates, 7 (4.3%) Turkey, 7 (4.3%) Israel, 7 (4.3%) India, 62 (37.8%) European Union, 6 (3.7%) China, 5 (3%) Canada, 40 (4.4%) Brazil, and 4 (2.4%) Australia.
3.2. Assessment of Cetrimonium Chloride and Behentrimonium Chloride Content of Cosmetics and Personal Care Products
The estimated average of Cetrimonium chloride content in rinse-off products was 0.793 (95% CI [0.63–0.95]). The estimated average of Cetrimonium chloride content in leave-on products was 0.789 (95% CI [0.51–1.1]). Of the 125 tested cosmetics and personal care products, 5 (4%) exceeded the recommended Cetrimonium chloride level in rinse-off hair products (2.5%), 10 (8%) exceeded the recommended Cetrimonium chloride level in leave-on hair products (1%), and 24 (61.5%) exceeded the recommended Cetrimonium chloride level used as a preservative in cosmetics products. Overall, 39 (23.8%) did not comply with the recommended Cetrimonium chloride levels in cosmetics and personal products (Table 2).
The results of the Cetrimonium chloride content stratified by sample characteristics of each sample are provided in Table 3.
The estimated average of Behentrimonium chloride in rinse-off products was 1.154 (95% CI [0.91–1.4]). The estimated average of Behentrimonium chloride in leave-on products was 0.361 (95% CI [0.16–0.56]). Of the 125 tested cosmetics and personal care products, 21 (53.8%) exceeded the recommended Behentrimonium chloride level used as preservatives in cosmetics products (Table 4).
The results of the Behentrimonium chloride content stratified by sample characteristics of each sample are provided in Table 5. Supplementary Materials shows the chromatograms for some analyzed cosmetics and personal care products (Supplementary Figure S1).
3.3. Comparison of Cetrimonium Chloride and Behentrimonium Chloride Content According to Country of Origin
The distribution of Cetrimonium chloride and Behentrimonium chloride content according to country of origin is presented in Table 6. The table also provides the comparison analysis along with p-values. These p-values were provided from the results of the Kruskal–Wallis test. There was a statistically significant difference in Cetrimonium chloride concentration according to country of origin (p < 0.001).
Post hoc analysis showed that significantly increased concentrations of Cetrimonium chloride were observed in products made in the United Arab Emirates (p = 0.009), Israel (p = 0.026), India (p = 0.008), and Brazil (p = 0.001) compared to products made in the United States.
Moreover, a statistically significant difference was found in concentrations of Behentrimonium chloride and country of origin (p = 0.002). In post hoc analysis, lower concentrations of Behentrimonium chloride were observed in products manufactured in Turkey (p = 0.012) and Brazil (p = 0.001) in comparison to products manufactured in the United States.
4. Discussion
Behentrimonium chloride and Cetrimonium chloride are known to be very effective hair conditioners with detangling, anti-frizz, and anti-static features. As per the technical regulations of the UAE cosmetics market, the concentrations of these agents in personal care/cosmetics products are strictly regulated. As far as we know, this is the first study to quantify and examine the Behentrimonium chloride and Cetrimonium chloride content in the UAE’s cosmetics and personal care product market to gauge the extent to which they adhere to the safety and health norms of the nation. As per this research, among all products, 61.5% were found to not adhere to the proposed levels of Cetrimonium chloride. In its entirety, this typically denotes grave health hazards linked to the utilization of cosmetics products. Similarly, 53.8% of these products were found to exceed the permitted levels of Behentrimonium chloride and were utilized as preservatives across personal care and cosmetics products.
Quality assurance-related problems may have led to this non-compliance. Variations with regard to quality are attributed mainly to a failure on the part of the manufacturer to adhere to good manufacturing practices (GMP) or their tendency to engage in unethical practices. For this reason, the technical problems undermining the tests’ accuracy must be duly addressed. Manufacturers must ensure that there is no compromise as far as specifications are concerned and that tests are conducted appropriately to determine the reliability of the preservatives’ content. They must also outsource certification/testing to an adequately proficient laboratory.
Alarmingly, this study finds that these non-compliant cosmetics products include dyes, preservatives, and fragrances—the most salient elements that cosmetics are known to contain and that can cause hypersensitivity [16,17]. Moreover, the continuous exposure to and everyday use of a broad array of these products containing all sorts of chemicals obtained from myriad sources may lead to the “cocktail effect” because of different substances’ synergistic interaction along with the “additive effect,” as the same ingredient is commonly found in several products. At the same time, it is necessary to devote more attention to leave-on products because they remain in contact with the skin for a longer period. Therefore, hazardous substances are likely to play a key role in damaging the health of humans [18,19].
To make matters worse, the use of these products on inflamed/irritated skin exacerbates the side effect-related risks. In such cases, the dangers of infection increase significantly when the subject makes use of a cosmetic that exceeds the preservatives’ recommended levels [14,15].
It is interesting to note that cosmetics products manufactured in the UAE, India, Brazil, and Israel contain higher Cetrimonium chloride levels in comparison to those manufactured in the United States. By contrast, lower Behentrimonium chloride levels have been found in products made in Brazil and Turkey, as compared to those made in the United States. This indicates the lack of a worldwide consensus on regulatory controls applicable to cosmetics products and stresses the need to establish a balanced framework of regulation whereby authorities can safeguard the consumption safety of cosmetics for humans and ensure that all claims of reliability and accuracy are not misleading.
The health hazards associated with these cosmetics products are snowballing into a major public health concern, as, over the past nine years, around 12% of users belonging to the general population have already witnessed adverse side effects following the use of at least one personal care and cosmetics product [20,21]. The growing body of literature on this issue reveals that the number of cases in which exposure to cosmetics leads to allergic reactions is growing in several nations [16,22]. Thyssen et al. conducted a study among Denmark’s citizens and showed that 33.6% of men and 56.7% of women have witnessed a side effect on at least one occasion during their lifetimes [23]. Nearly 10% of all people are known to suffer from allergy-induced irritation, general side effects, or hypersensitivity [16]. Wojciechowska et al. suggest that approximately 15% of people who use cosmetics experience side effects [24]. These findings agree with those of the study which suggests that cosmetics cause dermatitis in 8–15% of all cases [16,25].
Thus, it is amply clear that the use of cosmetics exposes most people across the world to a variety of possibly hazardous substances. Although the quantum of exposure might be negligible, and the side effects are often not properly understood, prolonged exposure to these chemicals may have deleterious effects on people’s wellbeing and health. Although the existing legislation considers these risks and subjects these substances to a threshold concentration, the risk of a “cocktail effect” caused by the use of a combination of products throughout the day cannot be denied. Moreover, it is possible to find the same ingredient in more than one product derived from more than one source (“additive effect”), thus overcoming the established safety threshold. This underscores the importance of enhancing the legislative approach, as many unsafe chemicals are still not prohibited from being sold in the market. Furthermore, there is a dire need to establish a unified cosmetovigilance worldwide. Such an all-encompassing strategy of public health can go a long way toward genuinely deriving information about cosmetics product safety and substances and prevent the risks linked to their usage, which can pose a threat to public health [26].
5. Conclusions
Although several structures for cosmetics’ quality and control across the globe are fairly comprehensive and intricate, there is a need to make them more rigorous to apply compliance with GMP and ensure regulatory control. Doing so would help enhance the inspection and regulation of cosmetics containing Behentrimonium chloride/Cetrimonium chloride preservatives.
Conceptualization, A.A.J. and S.S.A.-H.; methodology, M.S.; software, A.A.J.; validation, S.H.Z. and M.S.; formal analysis, A.A.J.; investigation, S.S.A.-H.; resources, S.H.Z.; data curation, A.A.J.; writing—original draft preparation, S.S.A.-H.; writing—review and editing, M.S.; visualization, M.S. and S.H.Z.; supervision, S.H.Z. All authors have read and agreed to the published version of the manuscript.
This research received no external funding.
The Institutional Review Board of An-Najah National University approved this study. Reference number: lnt.R. March.2021/10.
Not applicable.
The data presented in this study are available on request from the corresponding author.
The authors declare no conflict of interest.
Footnotes
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Number and percentages of sample baseline characteristics (n = 164).
| Characteristics | Groups | Frequency | Percentage |
|---|---|---|---|
| Cosmetic category | Hair and scalp products | 159 | 97% |
| Face and neck preparations | 5 | 3% | |
| Cosmetic application | Rinse-off | 125 | 76.2% |
| Leave-on | 39 | 23.8% | |
| Country of origin | United States | 16 | 9.8% |
| United Arab Emirates | 10 | 6.1% | |
| Turkey | 7 | 4.3% | |
| Israel | 7 | 4.3% | |
| India | 7 | 4.3% | |
| EU | 62 | 37.8% | |
| China | 6 | 3.7% | |
| Canada | 5 | 3% | |
| Brazil | 40 | 24.4% | |
| Australia | 4 | 2.4% |
Estimates of Cetrimonium chloride content from cosmetics and personal care products and Maximum Allowable Limit (n = 164).
| Parameters | Maximum Allowable Limit | Products Exceeding |
Estimates of Concentration (%) | ||||
|---|---|---|---|---|---|---|---|
| Rinse-off Products |
Leave-on Products |
||||||
| n | % | Mean ± SD | Median | Mean ± SD | Median | ||
| Cetrimonium chloride | 2.5% a (n = 125) | 5 | 4% | 0.793 ± 0.92 | 0.630 | 0.789 ± 0.85 | 0.746 |
| 1% b (n = 125) | 10 | 8% | |||||
| 0.5% c (n = 125) | 0 | 0 | |||||
| 0.1% d (n = 39) | 24 | 61.5% | |||||
Maximum allowable limits according to the EU and UAE cosmetics technical regulations. a: Rinse-off hair products. b: Leave-on hair products. c: Leave-on face products. d: For use as a preservative.
List of analyzed cosmetics and personal care products exceeding the maximum allowable limit of Cetrimonium chloride.
| Category | Product Description | Product Application | Cetrimonium Chloride (%) | Function | Country of Origin | Reason |
|---|---|---|---|---|---|---|
| Hair and scalp products | Anti frizz for hair | leave on | 1.3 | emulsifying | Brazil | B |
| Hair and scalp products | Professional hold & color | leave on | 1.5 | conditioning agent | India | B |
| Hair and scalp products | Professional hold & color | leave on | 1.5 | conditioning agent | India | B |
| Hair and scalp products | Professional hold & color | leave on | 1.5 | conditioning agent | India | B |
| Hair and scalp products | Professional care repair max masque | Rinse off | 3 | conditioning agent | India | A |
| Hair and scalp products | Protein straightening with argan oil | leave on | 2.5 | surfactants | EU | B |
| Hair and scalp products | Smoothing protein | Rinse off | 4 | surfactants | Brazil | A |
| Hair and scalp products | Hair conditioner | Rinse off | 1.4 | preservative | EU | D |
| Hair and scalp products | Hair balancing conditioner | Rinse off | 0.9 | preservative | EU | D |
| Hair and scalp products | Hair replenishing mask | Rinse off | 0.9 | preservative | EU | D |
| Hair and scalp products | Frizz off conditioner | Rinse off | 0.9 | preservative | EU | D |
| Hair and scalp products | Hair growth activation conditioner | Rinse off | 0.75 | preservative | EU | D |
| Hair and scalp products | Bleach blondes toning conditioner | Rinse off | 0.9 | preservative | EU | D |
| Hair and scalp products | Conditioning masque | Rinse off | 0.3 | preservative | India | D |
| Hair and scalp products | Scalp revitalizing shampoo | Rinse off | 0.5 | preservative | India | D |
| Hair and scalp products | Reconstructor nano | Rinse off | 0.62 | preservative | Brazil | D |
| Hair and scalp products | Reconstructor nano | Rinse off | 0.62 | preservative | Brazil | D |
| Hair and scalp products | Activation treatment | Rinse off | 0.9 | preservative | EU | D |
| Hair and scalp products | Hair conditioner | Rinse off | 5 | Antistatic | Turkey | A |
| Hair and scalp products | Hair conditioner | Rinse off | 3 | conditioning agent | Brazil | A |
| Hair and scalp products | Hair oil | leave on | 2 | emulsifying | Brazil | B |
| Hair and scalp products | Hair mask | Rinse off | 0.305 | preservative | EU | D |
| Hair and scalp products | Masque capillaire | Rinse off | 0.1387 | preservative | EU | D |
| Hair and scalp products | Hair mask | leave on | 3 | conditioning agent | Brazil | B |
| Hair and scalp products | Hair botox reconstructive | Rinse off | 1.5 | preservative | Brazil | D |
| Hair and scalp products | Keratin conditioner | Rinse off | 0.8 | preservative | Brazil | D |
| Hair and scalp products | Keratin shampoo | Rinse off | 0.2 | preservative | Australia | D |
| Hair and scalp products | Keratin treatment | leave on | 2 | conditioning agent | United Arab Emirates | B |
| Hair and scalp products | Hair cream | leave on | 0.15 | preservative | EU | D |
| Hair and scalp products | Hair balm | Rinse off | 0.63 | preservative | EU | D |
| Hair and scalp products | Hair | Rinse off | 0.63 | preservative | EU | D |
| Hair and scalp products | Hair conditioner | Rinse off | 3.75 | conditioning agent | United Arab Emirates | A |
| Hair and scalp products | Hair cream | leave on | 2.4 | surfactants | Brazil | B |
| Hair and scalp products | Arganoil nourishing treatment | Rinse off | 0.9 | preservative | EU | D |
| Hair and scalp products | Açai oil conditioner | leave on | 2.5 | conditioning agent | United Arab Emirates | B |
| Hair and scalp products | Hair botox reconstructive mask | Rinse off | 1.5 | preservative | Brazil | D |
| Hair and scalp products | Keratin conditioner | Rinse off | 0.8 | preservative | Brazil | D |
| Hair and scalp products | Hair conditioner | Rinse off | 0.6546 | preservative | EU | D |
| Hair and scalp products | Hair conditioner | Rinse off | 1.1755 | preservative | EU | D |
A: exceeding the limit of 2.5% in rinse-off hair products. B: Exceeding the limit of 1% in Leave-on hair products. C: exceeding the limit of 0.5% in Leave-on face products. D: exceeding the limit of 0.1% for use as a preservative.
Estimates of Behentrimonium chloride content from cosmetics and personal care products and Maximum Allowable Limit (n = 164).
| Parameters | Maximum Allowable Limit | Products Exceeding |
Estimates of Concentration (%) | ||||
|---|---|---|---|---|---|---|---|
| Rinse-off Products | Leave-on Products | ||||||
| n | % | Mean ± SD | Median | Mean ± SD | Median | ||
| Behentrimonium chloride | 5% a (n = 125) | 0 | 0 | 1.154 ± 1.4 | 0.70 | 0.361 ± 0.63 | 0.252 |
| 3% b (n = 125) | 0 | 0 | |||||
| 3% c (n = 125) | 0 | 0 | |||||
| 0.1% d (n = 39) | 21 | 53.8% | |||||
Maximum allowable limits according to the EU and UAE cosmetics technical regulations. a: Rinse-off hair products. b: Leave-on hair products. c: Leave-on face products. d: For use as a preservative.
List of analyzed cosmetics and personal care products exceeding the maximum allowable limit of Behentrimonium chloride used as a preservative.
| Category | Product Description | Application | Behentrimonium Chloride (%) | Function | Country of Origin |
|---|---|---|---|---|---|
| Hair and scalp products | Hair balancing conditioner | Rinse off | 0.428 | preservative | EU |
| Hair and scalp products | Hair replenishing mask | Rinse off | 1.4 | preservative | EU |
| Hair and scalp products | Hair growth activation conditioner | Rinse off | 1.4 | preservative | EU |
| Hair and scalp products | Deep conditioning masque | Rinse off | 1 | preservative | India |
| Hair and scalp products | Reconstructor nano | Rinse off | 0.78 | preservative | Brazil |
| Hair and scalp products | Reconstructor nano | Rinse off | 0.78 | preservative | Brazil |
| Hair and scalp products | Grow longer activation treatment | Rinse off | 0.2 | preservative | EU |
| Hair and scalp products | Hair masque | Rinse off | 2.5 | preservative | EU |
| Hair and scalp products | Masque capillaire | Rinse off | 2.5 | preservative | EU |
| Hair and scalp products | Hair botox reconstructive | Rinse off | 1.5 | preservative | Brazil |
| Hair and scalp products | Keratin conditioner | Rinse off | 0.495 | preservative | Brazil |
| Hair and scalp products | Intensive repair mask | Rinse off | 1.2 | preservative | EU |
| Hair and scalp products | Hair balm | Rinse off | 0.7 | preservative | EU |
| Hair and scalp products | Hair balm | Rinse off | 0.7 | preservative | EU |
| Hair and scalp products | Hair mask | Rinse off | 2.5 | preservative | EU |
| Hair and scalp products | Hair mask 1000ml | Rinse off | 0.7 | preservative | EU |
| Hair and scalp products | Hair botox reconstructive mask | Rinse off | 1.5 | preservative | Brazil |
| Hair and scalp products | Keratin conditioner | Rinse off | 0.495 | preservative | Brazil |
| Hair and scalp products | Hair conditioner | Rinse off | 1.3597 | preservative | EU |
| Hair and scalp products | Hair conditioner | Rinse off | 2.5173 | preservative | EU |
| Hair and scalp products | Arganoil nourishing conditioner | Rinse off | 3.825 | preservative | EU |
Comparison of Cetrimonium chloride and Behentrimonium chloride content according to country of origin.
| Country | Cetrimonium Chloride (%) | Behentrimonium Chloride (%) | ||||
|---|---|---|---|---|---|---|
| Mean | ±SD | p-Value | Mean | ±SD | p-Value | |
| United States | 0.15 | ±0.29 | <0.001 | 2.17 | ±1.1 | 0.002 |
| United Arab Emirates | 1.37 | ±1.22 | 0.780 | ±1.6 | ||
| Turkey | 1.003 | ±1.84 | 0.142 | ±0.38 | ||
| Israel | 1.40 | ±0.65 | 0.80 | ±1.5 | ||
| India | 1.53 | ±0.96 | 0.71 | ±1.5 | ||
| EU | 0.523 | ±0.64 | 1.16 | ±1.3 | ||
| China | 0.37 | ±0.42 | 0.33 | ±0.82 | ||
| Canada | 0.207 | ±0.44 | 1 | ±1.37 | ||
| Brazil | 1.21 | ±0.87 | 0.54 | ±0.89 | ||
| Australia | 0.603 | ±0.32 | 0.87 | ±1.7 | ||
Notes: p-values obtained from the Kruskal–Wallis test.
Supplementary Materials
The following are available online at
References
1. Anveden Berglind, I.; Meding, B.; Alderling, M. Life-style factors and hand eczema: A population-based study. Contact Dermat.; 2010; 63, (Suppl. 1), pp. 11-38. [DOI: https://dx.doi.org/10.1186/1471-5945-13-14]
2. Sasaya, H.; Oiso, N.; Kawara, S.; Kawada, A. Airborne contact dermatitis from cigarettes. Contact Dermat.; 2007; 56, pp. 173-174. [DOI: https://dx.doi.org/10.1111/j.1600-0536.2007.01041.x] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/17295699]
3. Aalto-Korte, K. Lichen contact allergy. Contact Dermat.; 2010; 63, (Suppl. 1), pp. 11-38. [DOI: https://dx.doi.org/10.4103/0019-5154.91832]
4. De Donno, A.; Idolo, A.; Bagordo, F. Epidemiology of jellyfish stings reported to summer health centres in the Salento peninsula (Italy). Contact Dermat.; 2009; 60, pp. 330-335. [DOI: https://dx.doi.org/10.1111/j.1600-0536.2009.01561.x]
5. Regulation (EC) no. 1223/2009 of the European Parliament and of the Council of 30 November 2009 on Cosmetic Products. Official Journal of the European Union. Available online: https://ec.europa.eu/health/sites/default/files/endocrine_disruptors/docs/cosmetic_1223_2009_regulation_en.pdf (accessed on 5 August 2021).
6. Patisaul, H.B.; Adewale, H.B. Long-term effects of environmental endocrine disruptors on reproductive physiology and behaviour. Front. Behav. Neurosci.; 2009; 3, pp. 1-18. [DOI: https://dx.doi.org/10.3389/neuro.08.010.2009]
7. Park, J.D.; Zheng, W. Human Exposure and health effects of inorganic and elemental mercury. J. Prev. Med. Public Health; 2012; 45, pp. 344-352. [DOI: https://dx.doi.org/10.3961/jpmph.2012.45.6.344] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/23230464]
8. Duarte, I.; Lage, A.C.C. Frequency of dermatoses associated with cosmetics. Contact Dermat.; 2007; 56, pp. 211-213. [DOI: https://dx.doi.org/10.1111/j.1600-0536.2006.01051.x] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/17343621]
9. European Commission. Commission Regulation (EU) No 866/2014 of 8 August 2014 Amending Annexes Iii, V and VI to Regulation (EC) No 1223/2009 of the European Parliament and the Council on Cosmetic Products; 866/2014 European Commission: Brussels, Belgium, 2014; Available online: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32014R0866 (accessed on 15 June 2021).
10. Consumer Products Safety Section (CPSS). Health Supplements Registration Procedures. Public Health & Safety Department. DM-PH&SD-P5-TG2. 2016; Available online: https://login.dm.gov.ae/wps/wcm/connect/f40bf93c-fbdc-46d8-bc6c-597a2 a1ff056/DM-PH%26SD-P5-TG2-%28Registration+of+HS%29+-Healthy+Supplements+Registration+Procedures.pdf?MOD=AJPERES (accessed on 11 June 2021).
11. Jairoun, A.A.; Al-Hemyari, S.S.; Shahwan, M.; Zyoud, S.E.H.; Ashames, A. Hidden formaldehyde content in cosmeceuticals containing preservatives that release formaldehyde and their compliance behaviors: Bridging the gap between compliance and local regulation. Cosmetics; 2020; 7, 93. [DOI: https://dx.doi.org/10.3390/cosmetics7040093]
12. Jairoun, A.A.; Al-Hemyari, S.S.; Shahwan, M.; Zyoud, S.E.H. An investigation into incidences of microbial contamination in cosmeceuticals in the UAE: Imbalances between preservation and microbial contamination. Cosmetics; 2020; 7, 92. [DOI: https://dx.doi.org/10.3390/cosmetics7040092]
13. Dubai Municipality Withdraws 6 Sterilizers for Hands that Do Not Meet Specifications from the Local Market. Localities-Health -Emirates Today [Internet]. Available online: https://www.emaratalyoum.com/local-section/health/2020-04-01-1.1328166a.(1) (accessed on 13 April 2021).
14. Jairoun, A.A.; Al-Hemyari, S.S.; Shahwan, M.; El-Dahiyat, F.; Jamshed, S. Scale validation for the identification of falsified hand sanitizer: Public and regulatory authorities perspectives from United Arab Emirates. BMC Public Health; 2020; 20, pp. 1-8. [DOI: https://dx.doi.org/10.1186/s12889-020-09707-0]
15. Jairoun, A.A.; Al-Hemyari, S.S.; Shahwan, M. The pandemic of COVID-19 and its implications for the purity and authenticity of alcohol-based hand sanitizers: The health risks associated with falsified sanitizers and recommendations for regulatory and public health bodies. Res. Soc. Adm. Pharm.; 2021; 17, pp. 2050-2051. [DOI: https://dx.doi.org/10.1016/j.sapharm.2020.04.014]
16. Wolf, R.; Wolf, D.; Tüzün, B.; Tüzün, Y. Cosmetics and contact dermatitis. Dermatol. Ther.; 2001; 14, pp. 181-187. [DOI: https://dx.doi.org/10.1046/j.1529-8019.2001.01025.x]
17. Klimańska, M.; Żmudzińska, M.; Jenerowicz, D.; Czarnecka-Ope-racz, M. The importance of exposure to contact allergens in patients with allergic contact dermatitis. Postep. Derm. Alergol.; 2011; 28, pp. 203-211.
18. Kartono, F.; Mailbach, H.I. Irritants in combination with a synergistic or additive effect on the skin response: An overview of tandem irritation studies. Contact Dermat.; 2006; 54, pp. 303-312. [DOI: https://dx.doi.org/10.1111/j.0105-1873.2006.00792.x]
19. Uter, W.; Yazar, K.; Kratz, E.M.; Mildau, G.; Lidén, C. Coupled exposure to ingredients of cosmetic products: I. Fragrances. Contact Dermat.; 2013; 69, pp. 335-341. [DOI: https://dx.doi.org/10.1111/cod.12125]
20. Nicolopoulou-Stamati, P.; Hens, L.; Sasco, A.J. Cosmetics as endocrine disruptors: Are they a health risk?. Rev. Endocr. Metab. Disord.; 2015; 16, pp. 373-383. [DOI: https://dx.doi.org/10.1007/s11154-016-9329-4]
21. Vigan, M.; Castelain, F. Cosmetovigilance: Definition, regulation and use “in practice”. Eur. J. Dermatol.; 2014; 24, pp. 643-649. [DOI: https://dx.doi.org/10.1684/ejd.2014.2493] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/25672787]
22. Lunder, T.; Kansky, A. Increase in contact allergy to fragrances: Patch-test results 1989–1998. Contact Dermat.; 2000; 43, pp. 107-109. [DOI: https://dx.doi.org/10.1034/j.1600-0536.2000.043002107.x] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/10945750]
23. Thyssen, J.P.; Linneberg, A.; Menné, T.; Nielsen, N.H.; Johansen, J.D. The prevalence and morbidity of sensitization to fragrance mix I in the general population. Br. J. Dermatol.; 2009; 161, pp. 95-101. [DOI: https://dx.doi.org/10.1111/j.1365-2133.2009.09157.x]
24. Wojciechowska, M.; Gocki, J.; Bartuzi, Z. The occurrence of cosmetics side effects. Selected Aspects of Health Care [Polish]; Bartuzi, Z. Nicolaus Copernicus University: Bydgoszcz, Poland, 2007; pp. 524-528.
25. Polańska, A.; Dańczak-Pazdrowska, A.; Silny, W.; Jenerowicz, D.; Osmola-Mańkowska, A.; Olek-Hrab, K. Evaluation of selected skin barrier functions in atopic dermatitis in relation to the disease severity and pruritus. Postep. Derm. Alergol.; 2012; 29, pp. 373-377. [DOI: https://dx.doi.org/10.5114/pdia.2012.31492]
26. Pereira, J.X.; Pereira, T.C. Cosmetics and its health risks. Glob. J. Med. Res.; 2018; 18, pp. 63-70. [DOI: https://dx.doi.org/10.34257/GJMRBVOL18IS2PG63]
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Abstract
Background: Exceeding the recommended Alkyl (C12-22) trimethyl ammonium bromide and chloride levels in cosmetics and personal care products is a serious health threat. Objectives: To quantify and investigate Cetrimonium chloride and Behentrimonium chloride in cosmetics and personal care products in the UAE market to gauge whether or not they adhered to requirements for safety and health. Methods: A total of 164 cosmetics products were collected and analyzed in this study. The gas chromatography–mass spectrometry (GC–MS) method was developed and validated for the determination of Cetrimonium chloride and Behentrimonium chloride surfactants in cosmetics products. With each product, Cetrimonium chloride and Behentrimonium chloride (%) were calculated. To test cross-group differences in Cetrimonium chloride and Behentrimonium chloride (%), Kruskal–Wallis test was applied. Results: Of the 125 tested cosmetics and personal care products, five (4%) exceeded the recommended Cetrimonium chloride level in rinse-off hair products (2.5%), 10 (8%) exceeded the recommended Cetrimonium chloride level in leave-on hair products (1%), and 24 (61.5%) exceeded the recommended Cetrimonium chloride level used as a preservative in cosmetics products. Moreover, of the 125 tested cosmetics and personal care products, 21 (53.8%) exceeded the recommended Behentrimonium chloride level used as preservatives in cosmetics products. Conclusions: Although several structures for cosmetics quality and control across the globe are fairly comprehensive and intricate, there is a need to make them more rigorous to apply compliance with GMP and ensure regulatory control. Doing so would help enhance the inspection and regulation of cosmetics containing Behentrimonium chloride/Cetrimonium chloride preservatives. Furthermore, there is a dire need to establish a unified cosmetovigilance worldwide.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Sabaa Saleh Al-Hemyari 2 ; Shahwan, Moyad 3
; Sa’ed H Zyoud 4
1 Discipline of Social and Administrative Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Pulau Pinang 1800, Malaysia;
2 Discipline of Social and Administrative Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Pulau Pinang 1800, Malaysia;
3 Department of Clinical Sciences, College of Pharmacy and Health Sciences, Ajman University, Ajman 346, United Arab Emirates;
4 Poison Control and Drug Information Center (PCDIC), College of Medicine and Health Sciences, An-Najah National University, Nablus 44839, Palestine;